Cohance Lifesciences Limited — Investor Meet, 06-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

A conference call for investors will take place on February 12, 2025, at 6:30 p.m. IST, where Suven Pharmaceuticals Ltd will discuss its Q3 and 9M FY25 financial results. The management team, including key executives from top leadership, will lead the discussion, followed by a Q&A session. Investors will have the opportunity to ask questions regarding the financial performance and strategic outlook. Pre-registration is required for participation, and the call will be accessible via various local and international dial-in numbers.